Compare SYBT & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SYBT | PAHC |
|---|---|---|
| Founded | 1904 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2009 | 2014 |
| Metric | SYBT | PAHC |
|---|---|---|
| Price | $70.54 | $55.10 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $76.40 | $41.25 |
| AVG Volume (30 Days) | 162.9K | ★ 235.4K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.82% | 0.88% |
| EPS Growth | 22.11 | ★ 1883.33 |
| EPS | ★ 4.75 | 1.32 |
| Revenue | $23,406,000.00 | ★ $833,350,000.00 |
| Revenue This Year | $17.31 | $17.03 |
| Revenue Next Year | $9.32 | $3.82 |
| P/E Ratio | ★ $14.82 | $41.30 |
| Revenue Growth | 3.37 | ★ 4.12 |
| 52 Week Low | $61.51 | $18.01 |
| 52 Week High | $83.83 | $60.08 |
| Indicator | SYBT | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 58.36 | 50.13 |
| Support Level | $64.73 | $50.72 |
| Resistance Level | $71.41 | $56.64 |
| Average True Range (ATR) | 1.59 | 2.30 |
| MACD | -0.10 | -0.52 |
| Stochastic Oscillator | 49.66 | 23.14 |
Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.